SPRY4 and cervical cancer: To determine its clinical relevance in cervical cancer, we examined correlations between SPRY4‐IT1 expression and clinicopathlogical factors such as age, histology, tumor size, FIGO stage, tumor differentiation, SCC‐Ag, Lymph node metastasis.